Compare DCX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DCX | SPRC |
|---|---|---|
| Founded | 2009 | 2004 |
| Country | Hong Kong | Israel |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1M | 2.7M |
| IPO Year | 2022 | 2014 |
| Metric | DCX | SPRC |
|---|---|---|
| Price | $1.13 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 170.2K | ★ 2.0M |
| Earning Date | 04-30-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7,708.85 |
| Revenue Next Year | N/A | $73.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.05 | $0.46 |
| 52 Week High | $7.45 | $15.79 |
| Indicator | DCX | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 42.44 | 15.38 |
| Support Level | $1.01 | N/A |
| Resistance Level | $1.32 | $1.78 |
| Average True Range (ATR) | 0.14 | 0.16 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 16.11 | 0.64 |
Digital Currency X Technology Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles, and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from the PRC.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.